CDKN2A and gastric carcinoma: EBV-positive gastric carcinomas are characterized by the monoclonal proliferation of EBV-infected cancer cells [14], global CpG island methylation of cancer-related genes [15], unique methylation patterns leading to CDKN2A (p16) downregulation [1, 16], and hyperactive T-cell activation [1, 11].